Product
Supplier
Encyclopedia
Inquiry
Home > News > Pharma News
ECHEMI chemical news

Pharma News

Pfizer and BioNTech announce publication of results from landmark Phase 3 trial

Pfizer and BioNTech announce publication of results from landmark Phase 3 trial

2020-12-23

Pfizer Inc.and BioNTech SE announced that the New England Journal of Medicine has published safety and final efficacy results from the pivotal Phase 3 trial of BNT162b2, their mRNA-based COVID-19 vaccine candidate.

Sanofi and GSK announced the postponement of their adjuvant recombinant protein-

Sanofi and GSK announced the postponement of their adjuvant recombinant protein-

2020-12-23

Sanofi and GSK announce a delay in their adjuvanted recombinant protein-based COVID-19 vaccine program to improve immune response in older adults. Phase 1/2 study interim results showed an immune response comparable to patients who recovered from COVID-19

FDA takes key action in fight against COVID-19 by issuing Emergency Use Authoriz

FDA takes key action in fight against COVID-19 by issuing Emergency Use Authoriz

2020-12-23

The U.S. Food and Drug Administration issued the first emergency use authorization (EUA) for a vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 16 years

Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patie

Novartis provides update on RUXCOVID study of ruxolitinib for hospitalized patie

2020-12-23

Novartis today announced that the Phase III RUXCOVID study evaluating ruxolitinib on top of standard of care (SoC) therapy compared to SoC treatment alone in patients with COVID-19 did not meet its primary endpoint.

2020-2025 China Ibuprofen API Market Report

2020-2025 China Ibuprofen API Market Report

2020-12-21

Ibuprofen is also known as ibuprofen and its chemical name is 2-(4-isobutylphenyl)propionic acid. It is a new generation of non-steroidal anti-inflammatory and analgesic drugs, suitable for the treatment of rheumatoid arthritis and rheumatoid arthritis.

The heavy pharmaceutical policy is about to be implemented

The heavy pharmaceutical policy is about to be implemented

2020-12-18

The new "Chinese Pharmacopoeia" is published in four parts and contains 5911 varieties, including 319 new varieties and 3177 revised products. The industry generally believes that the promulgation and implementation of the new version of the Pha

Export of raw materials to India may face greater challenges

Export of raw materials to India may face greater challenges

2020-12-17

As China's largest export destination country for APIs, India accounts for 17% of China's total API exports. According to reports, 70% of the APIs needed by India come from China

Forecast of TOP 10 global best-selling drugs in 2021

Forecast of TOP 10 global best-selling drugs in 2021

2020-12-15

On December 11, Nature Reviews Drug Discovery published its 2021 global best-selling drug TOP10 forecast (as shown below). The cumulative sales revenue of these 10 drugs in 2021 will reach 109.75 billion U.S. dollars.

Antidiabetic drugs are involved in the 'price reduction' storm!

Antidiabetic drugs are involved in the 'price reduction' storm!

2020-12-14

On December 9, a "Notice on Reporting the Purchasing Data of the Fourth Batch of National Organizations for Centralized Procurement of Drugs" was released in the industry.

Novartis siRNA Therapy Receives EU Marketing Approval

Novartis siRNA Therapy Receives EU Marketing Approval

2020-12-14

Novartis announced on the 12th that its siRNA therapy Leqvio (inclisiran) has been approved by the European Commission for the treatment of adult hypercholesterolemia and mixed dyslipidemia.

Oral drug blocks SARS-CoV-2 transmission

Oral drug blocks SARS-CoV-2 transmission

2020-12-14

Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.

Moderna announces first participants dosed in Phase 2/3 study of COVID-19 vaccin

Moderna announces first participants dosed in Phase 2/3 study of COVID-19 vaccin

2020-12-14

Moderna Inc. today announced that the first adolescent participants have been dosed in the Phase 2/3 study of mRNA-1273, the Company’s vaccine candidate against COVID-19, in adolescents ages 12 to less than 18.

J&J trims the size of its phase 3 COVID-19 vaccine trial

J&J trims the size of its phase 3 COVID-19 vaccine trial

2020-12-14

Johnson & Johnson (J&J) announced on Wednesday that it will decrease the size of its US-based phase 3 trial currently testing its COVID-19 vaccine as cases surge across the country.

FDA expert panel recommends EUA for Pfizer/BioNTech COVID-19 vaccine

FDA expert panel recommends EUA for Pfizer/BioNTech COVID-19 vaccine

2020-12-14

A US Food and Drug Administration (FDA) advisory committee panel recommended Pfizer/BioNTech’s COVID-19 vaccine for emergency use following an hours long meeting held yesterday.

Quaternary ammonium salt disinfectants in China

Quaternary ammonium salt disinfectants in China

2020-12-10

With the outbreak of the new coronavirus pneumonia in early 2020, "disinfection and sterilization" has almost become a daily necessity, and the supply of disinfectant products is also in short supply.

Inching toward first-in-class new drugs

Inching toward first-in-class new drugs

2020-12-08

When I started reporting on healthcare around 10 year ago, domestic drugs for cancer treatment were often seen as being less effective than foreign medicine.

Sinovac secures $500 million in funding for COVID-19 vaccine development

Sinovac secures $500 million in funding for COVID-19 vaccine development

2020-12-08

Sinovac Biotech Ltd, a leading provider of biopharmaceutical products in China, announced Monday that Sinovac Life Sciences Co Ltd

Top 1000 global pharmaceutical companies are released, China has 208

Top 1000 global pharmaceutical companies are released, China has 208

2020-12-08

Recently, the global investment bank Torreya released the "Global Top 1000 Pharmaceutical Companies Report". The report conducted a tracking study of 30,000 pharmaceutical companies around the world since 2012, and finally released the TOP1000 r

Export of APIs may benefit Biden's victory

Export of APIs may benefit Biden's victory

2020-12-07

The United States ranks second in my country's list of export destinations for APIs. From 2017 to 2018, my country's export of APIs to the United States achieved rapid growth, with year-on-year growth rates reaching 23.84% and 8.87% respectively.

Kangfang bio-targeting IL-4R new drug approved clinically in the United States

Kangfang bio-targeting IL-4R new drug approved clinically in the United States

2020-12-02

On December 1, Kangfang Bio announced its independent research and development of the innovative drug AK120, which was approved by the FDA to carry out a phase 1b clinical study for the treatment of moderate to severe atopic dermatitis in the United State

  • Pharmaceutical Industry Overview

    The magazine has been officially published in August 2024 and will be distributed at CPHI Korea 2024 and CPHI Milan 2024. It could be permanently available for download online. We sincerely invite you to join us in the publicity, making full use of the influence of the journal to promote your brand & products, expand your corporate influence in the global market.
    Published in: Aug. 2024

ECHEMI Partner

Complaint
Email:
Message:
Send Message